Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ganglioneuroblastoma × Influenza Vaccines × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Influenza, Human 16 Neoplasms 8 Leukemia, Lymphocytic, Chronic, B-Cell 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Myelodysplastic Syndromes 4 Multiple Myeloma 4 Lymphoma 4 Leukemia, Myeloid, Acute 4 Colorectal Neoplasms 4 Lymphoma, Non-Hodgkin 3 Leukemia 3 Carcinoma, Non-Small-Cell Lung 3 Recurrence 2 Pancreatic Neoplasms 2 Neuroblastoma 2 Neoplasms, Plasma Cell 2 Melanoma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Hodgkin Disease 2 Central Nervous System Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Anemia, Aplastic 2 Waldenstrom Macroglobulinemia 1 Virus Diseases 1 Vaccine-Preventable Diseases 1 Vaccination Hesitancy 1 Triple Negative Breast Neoplasms 1

Interventions

Cyclophosphamide 8 dinutuximab 7 Magnetic Resonance Spectroscopy 7 Topotecan 6 Doxorubicin 6 sargramostim 5 Vincristine 5 Stem Cell Transplantation 5 Radiation 5 Platinum 5 Melphalan 5 Isotretinoin 5 Colony-Stimulating Factors 5 Cisplatin 5 Biopsy 5 1,2-diaminocyclohexaneplatinum II citrate 5 Temozolomide 4 Specimen Handling 4 Irinotecan 4 Etoposide 4 Congresses as Topic 4 Carboplatin 4 Thiotepa 3 Busulfan 3 3-Iodobenzylguanidine 3 etoposide phosphate 2 Razoxane 2 Dexrazoxane 2 temsirolimus 1 lorlatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07502287 2026-03-30

DUAL-NK-NB

Beijing Biotech

Phase 1/2 Recruiting

Neuroblastoma, Recurrence, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡